High presence of extended-spectrum β-lactamases and resistance to quinolones in clinical isolates of Escherichia coli

Microbiological Research

Volumn 162, Issue 4, 2007, Pages 347-354

  Sorlózano, Antonio ^a   Gutiérrez, José ^a   de Dios Luna, Juan ^a   Oteo, Jesús ^b   Liébana, José ^a   Soto, María José ^a   Piédrola, Gonzalo ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

CTX M9; Escherichia coli; PFGE; Quinolones

Indexed keywords

ANTIBIOTICS; BIOCHEMISTRY; ENZYME ACTIVITY; MOLECULAR STRUCTURE; SPECTRUM ANALYSIS;

CLONAL DISTRIBUTION; DISK DIFFUSION PROCEDURE; LOWER AMINOGLYCOSIDE ACTIVITY; MOLECULAR STUDY;

ESCHERICHIA COLI;

ANTIBIOTICS; BACTERIUM; DIFFUSION; ENZYME ACTIVITY;

ESCHERICHIA COLI;

EID: 34748839527     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2006.02.003     Document Type: Article

References (33)

1. Baquero F., Reguera J.A., Ojeda M., Cantón R., Martínez J.L., and Martínez-Beltrán J. Escherichia coli con resistencia a cefalosporinas de tercera generación codificadas por betalactamasas de tipo plasmídico: primer brote en España. Rev. Esp. Microbiol. Clin. (1988) 581-582
2. Bradford P.A. Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14 (2001) 933-951
3. Bush K., Jacoby G.A., and Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39 (1995) 1211-1233
4. Cantón R., Pérez-Vázquez M., Oliver A., Sánchez del Saz B., Gutiérrez M.O., Martínez-Ferrer M., and Baquero F. Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing. J. Clin. Microbiol. 38 (2000) 1339-1346
5. Danel F., Hall L.M.C., Duke B., Gur D., and Livermore D.M. OXA-17, a further extended-spectrum β-lactamase variant of OXA-10 β-lactamase isolated from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43 (1999) 1362-1366
6. Daza R., Gutiérrez J., and Piédrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int. J. Antimicrob. Agents 18 (2001) 211-215
7. Edelstein M., Pimkin M., Palagin I., Edelstein I., and Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae in Russian Hospitals. Antimicrob. Agents Chemother. 47 (2003) 3724-3732
8. Fernández-Rodríguez A., Reguera J.A., Pérez-Díaz J.C., Picazo J.J., and Baquero F. 1st Spanish epidemic of plasmid resistance to 3rd generation cephalosporins: the implication of SHV-2. Enferm. Infecc. Microbiol. Clin. 10 (1992) 456-461
9. Hadziyannis E., Tuohy M., Thomas L., Procop G.W., Washington J.A., and Hall G.S. Screening and confirmatory testing for extended spectrum β-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates. Diagn. Microbiol. Infect. Dis. 36 (2000) 113-117
10. Hernández J.R., Pascual A., Cantón R., Martínez-Martínez L., and the Hospital Infection Study Group (GEIH). Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals (GEIH-BLEE Project 2002). Enferm. Infecc. Microbiol. Clin. 21 (2003) 77-82
11. Humeniuk C., Arlet G., Gautier V., Grimont P., Labia R., and Philippon A. β-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob. Agents Chemother. 46 (2002) 3045-3049
12. Lautenbach E., Patel J.B., Bilker W.B., Edelstein P.H., and Fishman N.O. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32 (2001) 1162-1171
13. Lautenbach E., Strom B.L., Bilker W.B., Patel J.B., Edelstein P.H., and Fishman N.O. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae. Clin. Infect. Dis. 33 (2001) 1288-1294
14. Martínez-Martínez L., Pascual A., and Jacoby G.A. Quinolone resistance from a transferable plasmid. Lancet 351 (1998) 797-799
15. Maslow J.N., Slutky A.M., and Arbeit R.D. Application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing D.H., Smith T.F., Tenover F.C., and White T.J. (Eds). Diagnostic Molecular Microbiology: Principles and Applications (1993), American Society for Microbiology, Washington, DC 563-571
16. Mirelis B., Navarro F., Miró E., Mesa R.J., Coll P., and Prats G. Community transmission of extended-spectrum β-lactamase. Emerg. Infect. Dis. 9 (2003) 1024-1025
17. Munday C.J., Xiong J., Li C., Shen D., and Hawkey P.M. Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People's Republic of China. Int. J. Antimicrob. Agents 23 (2004) 175-180
18. Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.H. Manual of Clinical Microbiology. eighth ed. (2003), ASM, Washington, DC
19. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S14. NCCLS, Wayne, PA.
20. Nicolas M.H., Jarlier V., Honore N., Philippon A., and Cole S.T. Molecular characterization of the gene encoding SHV-3 β-lactamase responsible for the transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 33 (1989) 2096-2100
21. Oliver A., Pérez-Díaz J.C., Coque T.M., Baquero F., and Cantón R. Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-10) isolated in Spain. Antimicrob. Agents Chemother. 45 (2001) 616-620
22. Pagani L., Dell'Amico E., Migliavacca R., D'Andrea M.M., Giacobone E., Amicosante G., Romero E., and Rossolini G.M. Multiple CTX-M type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a Hospital in Northern Italy. J. Clin. Microbiol. 41 (2003) 4264-4269
23. Peña C., Pujol M., Ardanuy C., Ricart A., Pallares R., Linares J., Ariza J., and Gudiol F. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 42 (1998) 53-58
24. Rodríguez-Baño J., Navarro M.D., Romero L., Martínez-Martínez L., Muniain M.A., Perea E.J., Pérez-Cano R., and Pascual A. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase producing Escherichia coli in nonhospitalized patients. J. Clin. Microbiol. 42 (2004) 1089-1094
25. Rossolini G.M., Franceschini N., Lauretti L., Caravelli B., Riccio M.L., Galleni M., Frere J.M., and Amicosante G. Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaCME) encoding an extended-spectrum class A β-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER β-lactamases. Antimicrob. Agents Chemother. 43 (1999) 2193-2199
26. Sabaté M., Tarragó R., Navarro F., Miró E., Verges C., Barbe J., and Prats G. Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrob. Agents Chemother. 44 (2000) 1970-1973
27. Sabaté M., Miró E., Navarro F., Verges C., Aliaga R., Mirelis B., and Prats G. β-lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain). J. Antimicrob. Chemother. 49 (2002) 989-997
28. Sorlózano A., Gutiérrez J., Fernández F., Soto M.J., and Piédrola G. A preliminary study on the presence of extended-spectrum beta-lactamases (ESBL) in clinical isolates of Escherichia coli in Granada (Spain). Ann. Microbiol. 54 (2004) 227-232
29. Sorlózano A., Gutiérrez J., Palanca M., Soto M.J., and Piédrola G. High incidence of extended-spectrum β-lactamases among outpatient clinical isolates of Escherichia coli: A phenotypic assessment of NCCLS guidelines and a commercial method. Diagn. Microbiol. Infect. Dis. 50 (2004) 131-134
30. Sorlózano A., Gutiérrez J., Piédrota G., and Soto M.J. Acceptable performance of Vitek 2 system to detect extended-spectrum beta-lactamases in clinical isolates of Escherichia coli: A comparative study of phenotypic commercial methods and NCCLS guidelines. Diagn. Microbiol. Infect. Dis. 51 (2005) 191-193
31. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., and Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33 (1995) 2233-2239
32. Valverde A., Coque T.M., Sánchez-Moreno M.P., Rollán A., Baquero F., and Cantón R. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J. Clin. Microbiol. 42 (2004) 4769-4775
33. Wiener J., Quinn J.P., Bradford P.A., Goering R.W., Nathan C., Bush K., and Weinstein R.A. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281 (1999) 517-523